To calculate the weekly performance on my portfolio I take the close from last Friday to work out the percentage increase/decrease in each stock. This is compared to the ASX 200 (Code: XJO) and the Small Ords (XSO). The Small Ords is comprised of companies included in the ASX 300 index, but not in the ASX 100 index. I include the Small Ords in my comparison as it helps highlight the markets appetite for risk.
Market: | Close (Friday 16/12/11): | Close (Friday 23/12/11): | Percentage Change: |
XJO | 4159 | 4140 | -0.46% |
XSO | 2317 | 2264 | -2.29% |
Last week the XSO severely underperformed by dropping 2.29% compared to a relatively modest fall of 0.46% on the ASX 200. This clearly signals that risk is off and people are shying aware from small to mid-cap stocks. This risk aversion was evident in my portfolio with both MHM and OBJ suffering from the pressure.
Code: | Weighting: | Share Price Friday (16/12/2011) | Share Price Friday (23/12/2011) | Percentage Change: | Weighted Change: |
OBJ | 19.38% | 0.019 | 0.018 | -5.26% | -1.02% |
MHM | 20.62% | 0.995 | 0.900 | -9.55% | -1.97% |
KGL | 26.89% | 0.115 | 0.120 | 4.35% | 1.17% |
Cash | 33.11% | 0% | 0.00% | ||
TOTAL | 100.00% | -3.488% | -1.82% |
OBJ closed down just over 5% with MHM having another shocking week to lose 9.55%. It certainly seems that we will get no solid gains in that stock until news on the financing and construction timeframe are provided. It is also clear that I pulled the trigger too early when I bought some more just above $1. However, we live and learn and it is something that I will be more wary of when purchasing shares in the future.
Kentor did have a good week and managed a gain of 4.35%. New on Andash, the Burnakura feasibility and Jervois update are so close I can almost see the announcement popping up onto my screen now. I expect news will be forthcoming within the next 2-3 weeks.
My cash holding continues to act as a bit of a buffer and helped the portfolio limit its losses to 1.82% for the week, which was not too bad in my opinion.
Code: | Weighting: | Share Price Friday (16/12/2011) | Share Price Friday (23/12/2011) | Percentage Change: | Weighted Change: |
OBJ | 28.97% | 0.019 | 0.018 | -5.26% | -1.52% |
MHM | 30.82% | 0.995 | 0.900 | -9.55% | -2.94% |
KGL | 40.21% | 0.115 | 0.120 | 4.35% | 1.75% |
TOTAL | 100.00% | -2.72% |
Removing cash from the portfolio shows a drop of 2.72% which is more in line with the general mood and sentiment that we experienced.
Code: | Weighting: | Purchase Price | Current Price: | Percentage Change: | Weighted Change: |
OBJ | 22.94% | 0.023 | 0.018 | -21.74% | -4.99% |
MHM | 22.29% | 1.100 | 0.900 | -18.18% | -4.05% |
KGL | 22.41% | 0.098 | 0.120 | 22.45% | 5.03% |
TOTAL | 67.63% | -4.01% |
The portfolio remains slightly underwater with a total loss of 4.01% (excluding the impact of cash). The main drag on performance is both OBJ and MHM. I am not as concerned about OBJ as news in the bio-tech space could easily see the stock rally by 100% or more within a relatively short space of time. And as I have mentioned before if you back management and the technology it is always better be on the train than arrive too late at the station.
No comments:
Post a Comment